Free tool
FAERS Monitor: Doryx Mpc
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050795 or its brand name (Doryx Mpc, Doxycycline Hyclate). Reports on generic versions are filed under their own applications.
Reports
17,469
Serious
10,251
59% of reports
Hospitalization
4,803
Death reported
2,363
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug hypersensitivity2,304
- fatigue1,817
- nausea1,715
- pain1,489
- rash1,463
- off label use1,432
- drug ineffective1,415
- headache1,402
- diarrhoea1,371
- dyspnoea1,349
- vomiting1,339
- pruritus1,166
- pneumonia1,157
- dizziness1,117
- condition aggravated1,094
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 15 |
| 2005 | 14 |
| 2006 | 23 |
| 2007 | 25 |
| 2008 | 36 |
| 2009 | 88 |
| 2010 | 107 |
| 2011 | 142 |
| 2012 | 255 |
| 2013 | 251 |
| 2014 | 341 |
| 2015 | 561 |
| 2016 | 1,058 |
| 2017 | 1,008 |
| 2018 | 1,397 |
| 2019 | 1,669 |
| 2020 | 1,510 |
| 2021 | 1,127 |
| 2022 | 1,187 |
| 2023 | 1,262 |
| 2024 | 1,875 |
| 2025 | 2,125 |
| 2026 | 1,392 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,690 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug hypersensitivitySignal | 2,304 | 14.5 | 14.0 | 28,856 |
| condition aggravatedSignal | 1,094 | 4.3 | 4.1 | 2,844 |
| pneumoniaSignal | 1,157 | 4.3 | 4.1 | 2,978 |
| rashSignal | 1,463 | 4.1 | 3.9 | 3,419 |
| pruritusSignal | 1,166 | 3.7 | 3.5 | 2,288 |
| vomitingSignal | 1,339 | 3.4 | 3.3 | 2,356 |
| painSignal | 1,489 | 2.9 | 2.8 | 1,934 |
| dyspnoeaSignal | 1,349 | 2.9 | 2.7 | 1,688 |
| fatigueSignal | 1,817 | 2.8 | 2.7 | 2,200 |
| dizzinessSignal | 1,117 | 2.7 | 2.6 | 1,220 |
| headacheSignal | 1,402 | 2.7 | 2.6 | 1,537 |
| nauseaSignal | 1,715 | 2.6 | 2.5 | 1,768 |
| diarrhoeaSignal | 1,371 | 2.6 | 2.4 | 1,341 |
| off label use | 1,432 | 2.0 | 1.9 | 712 |
| drug ineffective | 1,415 | 1.3 | 1.2 | 100 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.